QUANTA THERAPEUTICS, INC.

Profile

Company Names

QUANTA THERAPEUTICS, INC.

Addresses

TWO TOWER PLACE, FLOOR 17, SOUTH SAN FRANCISCO, CA 94080

2 TOWER PLACE, FLOOR 17, SAN FRANCISCO, CA 94080

455 MISSION BAY BLVD. SOUTH RM 322, SAN FRANCISCO, CA 94158

Phone Numbers

(970) 742-4190
(650) 799-8230

 

Entity Type:

CORPORATION

Industry:

BIOTECHNOLOGY

Year Incorporated:

2018

State Incorporated:

DELAWARE

Total Amount Raised:

$146,344,588.00

Number of Funding Rounds:

3
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
3
2023-05-10 
$76,192,272.00 
$89,098,282.00 
$12,906,010.00 
Equity 
2
2023-02-09 
$29,999,993.00 
$29,999,993.00 
$0.00 
Equity 
1
2021-10-20 
$40,152,323.00 
$70,152,314.00 
$29,999,991.00 
Equity 
People
First Name
Middle Name
Last Name
Titles
Related Companies
LEONARDO 
 
FAORO 
EXECUTIVE OFFICER
QUANTA THERAPEUTICS, INC.
MARIA 
 
FARDIS 
DIRECTOR
LION BIOTECHNOLOGIES, INC.   |  QUANTA THERAPEUTICS, INC.   |  AIRNEXIS THERAPEUTICS, INC.
ARJUN 
 
GOYAL 
DIRECTOR
VIDA VENTURES, LLC   |  VVAG SPECIAL FUND LLC   |  VIDA VENTURES II, LLC   |  VIDA VENTURES II-A, LLC   |  SCORPION THERAPEUTICS, INC.   |  QUANTA THERAPEUTICS, INC.   |  ALTEROME THERAPEUTICS, INC.   |  THIRD ARC BIO, INC.   |  HALDA THERAPEUTICS, LLC   |  AFFINI-T THERAPEUTICS, INC.
YING 
 
HUANG 
DIRECTOR
QUANTA THERAPEUTICS, INC.   |  DEEPBLUE VALUE ADD FUND 2025 LLC
RAJUL 
 
JAIN 
DIRECTOR
NEOGENE THERAPEUTICS, INC.   |  LB PHARMACEUTICALS INC   |  CAPSTAN THERAPEUTICS, INC.   |  QUANTA THERAPEUTICS, INC.   |  SONOTHERA, INC.
MAHA 
 
KATABI 
DIRECTOR
EFFECTOR THERAPEUTICS, INC.   |  APELLIS PHARMACEUTICALS, INC.   |  AEROVATE THERAPEUTICS, INC.   |  VERA THERAPEUTICS, INC.   |  GYROSCOPE THERAPEUTICS LTD   |  QUANTA THERAPEUTICS, INC.   |  SOFINNOVA VENTURE PARTNERS XI, L.P.   |  RAYZEBIO, INC.   |  MAREA THERAPEUTICS, INC.   |  SOFINNOVA VENTURE PARTNERS XII, L.P.   |  STAR THERAPEUTICS LLC
DEREK 
 
METZGER 
EXECUTIVE OFFICER
QUANTA THERAPEUTICS, INC.
PERRY 
 
NISEN 
EXECUTIVE OFFICER, DIRECTOR
QUANTA THERAPEUTICS, INC.
CAMERON 
 
PITT 
EXECUTIVE OFFICER, DIRECTOR
QUANTA THERAPEUTICS, INC.
SAMUEL 
 
SAKS 
DIRECTOR
AUSPEX PHARMACEUTICALS, INC.   |  TONIX PHARMACEUTICALS HOLDING CORP.   |  BULLET BIOTECHNOLOGY, INC.   |  HINGE BIO, INC.   |  QUANTA THERAPEUTICS, INC.
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2026-06-24
D/A
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2023-05-10 
2023-05-25
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2023-05-10 
2023-02-17
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2023-02-09 
2021-11-03
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2021-10-20 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#